Last Price$23.80.8%
Market Cap$45.5B
0.1%
Peers median - 2.3%
8.6%
Peers median - 12.8%
90.2%
Peers median - 104.8%
10.1%
Peers median - 24.1%
Competing with KVUE
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$45.5B | 5.8 | $21.1 11.3% overvalued | 29.2% | $15.5B | $1,335.0M | 0.1% | 8.6% | 57.9% | 10.1% | 90.2% | |
$411.8B | 7.1 | $135.9 22.6% overvalued | 12.1% | $84.3B | $16.7B | 0.5% | 19.8% | 51.3% | 19.2% | 67.4% | |
$143.6B | 7.0 | $90.7 57.2% undervalued | 20.3% | €120.4B | €15.8B | 7.0% | 13.1% | 71.4% | 31.3% | 142.1% | |
$75.3B | 7.0 | $83.3 10.2% overvalued | 8.6% | $20.1B | $3,546.0M | 3.3% | 17.6% | 60.5% | 30.9% | 1,564.7% | |
$47.9B | 6.4 | $160.0 11.6% undervalued | 20.3% | $20.1B | $2,513.0M | (1.8%) | 12.5% | 35.8% | 28.9% | 705.1% | |
$27.1B | 6.3 | $79.8 28.8% overvalued | 11.9% | $6,107.1M | $976.4M | 4.1% | 16.0% | 45.2% | 8.9% | 41.1% | |
$25.7B | 5.0 | $93.6 33.4% undervalued | (51.7%) | $15.2B | $1,145.0M | 0.1% | 7.6% | 73.1% | 0.2% | 225.1% | |
$19.3B | 6.6 | $117.2 24.8% overvalued | 5.0% | $7,165.0M | $695.0M | (2.0%) | 9.7% | 44.5% | 38.2% | 2,555.4% | |
$9,261.6M | 7.3 | $22.2 45.4% overvalued | 176.7% | $1,476.5M | $198.3M | 69.3% | 13.4% | 76.6% | 55.5% | 2.4% | |
$4,901.6M | 5.1 | $15.4 182.3% undervalued | (56.1%) | $6,090.4M | $293.5M | 1.3% | 4.8% | 64.6% | 7.0% | 7.8% | |
$3,814.9M | 6.1 | $64.1 0.4% undervalued | (69.5%) | $1,302.0M | $24.6M | 46.3% | 1.9% | 71.1% | 15.2% | 39.4% |
Compare KVUE Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
Kenvue Inc.KVUE
3.4x
0.1%
(40.0%)
6.7%
Median Peer Set
3.1x
2.9%
(4.3%)
10.2%
Church & Dwight Co., Inc.CHD
4.6x
4.1%
(22.7%)
9.6%
Colgate-Palmolive CompanyCL
4.1x
3.3%
27.0%
14.4%
The Clorox CompanyCLX
3.1x
(4.0%)
86.0%
3.9%
Coty Inc.COTY
0.8x
10.2%
(85.0%)
1.5%
The Estée Lauder Companies Inc.EL
2.1x
(1.9%)
(61.2%)
2.5%
e.l.f. Beauty, Inc.ELF
3.1x
76.9%
99.1%
12.5%
Hims & Hers Health, Inc.HIMS
6.1x
65.5%
(65.6%)
(2.7%)
Kimberly-Clark CorporationKMB
2.7x
(1.8%)
45.5%
12.7%
The Procter & Gamble CompanyPG
5.2x
2.5%
3.8%
17.7%
Unilever PLCUL
1.3x
1.8%
(12.4%)
10.9%
Compare KVUE Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Kenvue Inc. (KVUE) revenue growth compare to peers and the industry?
Kenvue Inc. (KVUE) revenue growth is 0.1%, compared to the peers' median of 2.3%.
2. How does Kenvue Inc. (KVUE) Free Cash Flow (FCF) margin compare to peers and the industry?
Kenvue Inc. (KVUE) FCF margin is 8.6%, compared to the peers' median of 12.8%.
3. How does Kenvue Inc. (KVUE) Total Debt to Equity ratio compare to peers and the industry?
Kenvue Inc. (KVUE) Total Debt to Equity ratio is 90.2%, compared to the peers' median of 104.8%.
4. How does Kenvue Inc. (KVUE) ROIC (Return on Invested Capital) compare to peers and the industry?
Kenvue Inc. (KVUE) ROIC is 10.1%, compared to the peers' median of 24.1%.